Literature DB >> 1259385

Effect of temperature on the rate of the transparent to opaque colony type transition in Mycobacterium avium.

C L Woodley, H L David.   

Abstract

The results of drug susceptibility tests were found to be affected by changes that occur spontaneously in populations of Mycobacterium avium maintained in the laboratory. Because the transparent colony type variant was resistant to antituberculosis chemotherapeutic agents and the opaque colony type variant was usually susceptible to these agents, the transition of transparent to opaque colony type was investigated. The rate of the transition was found to be temperature dependent and, in agreement with a previous report, was found to be about 10(-4) to 10(-5) per generation at 37 C. Reversion was found to occur at a rate of 10(-6) to 10(-7) at 37 C. The mutation rate from susceptibility to resistance to rifampin, kanamycin, and erythromycin was about 10(-8) to 10(-9) mutations per bacterium per generation. Judged from our data, the high rate of the transparent to opaque variation was not caused either by mutator effects or by the occurrence of extrachromosomal genes in these bacteria, but could have been due to selective mechanisms still incompletely understood.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1259385      PMCID: PMC429484          DOI: 10.1128/AAC.9.1.113

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Ultraviolet-sensitive mutator strain of Escherichia coli K-12.

Authors:  E C Siegel
Journal:  J Bacteriol       Date:  1973-01       Impact factor: 3.490

2.  Response of Mycobacterium avium to ultraviolet irradiation.

Authors:  C M McCarthy; J O Schaefer
Journal:  Appl Microbiol       Date:  1974-07

3.  Isolation, characterization, and genetic analysis of mutator genes in Escherichia coli B and K-12.

Authors:  R M Liberfarb; V Bryson
Journal:  J Bacteriol       Date:  1970-10       Impact factor: 3.490

4.  Mycobacterium intracellulare. Maintenance of pathogenicity in relationship to lyophilization and colony form.

Authors:  F P Dunbar; I Pejovic; R Cacciatore; L Peric-Golia; E H Runyon
Journal:  Scand J Respir Dis       Date:  1968

5.  Pathogenicity of transparent, opaque, and rough variants of Mycobacterium avium in chickens and mice.

Authors:  W B Schaefer; C L Davis; M L Cohn
Journal:  Am Rev Respir Dis       Date:  1970-10

6.  Relationship of colonial morphology to virulence for chickens of Mycobacterium avium and the nonphotochromogens.

Authors:  J M Moehring; M R Solotorovsky
Journal:  Am Rev Respir Dis       Date:  1965-11

7.  Dissociation in M. avium.

Authors:  S R Pattyn; M T Hermans-Boveroulle
Journal:  Pneumonologie       Date:  1970

8.  Response of Mycobacteria to ultraviolet light radiation.

Authors:  H L David
Journal:  Am Rev Respir Dis       Date:  1973-11

9.  Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis.

Authors:  H L David
Journal:  Appl Microbiol       Date:  1970-11

10.  Genetic instability of an ultraviolet-sensitive mutant of Proteus mirabilis.

Authors:  H Böhme
Journal:  Biochem Biophys Res Commun       Date:  1967-07-21       Impact factor: 3.575

View more
  18 in total

1.  Evaluation of growth promotion and inhibition from mycobactins and nonmycobacterial siderophores (Desferrioxamine and FR160) in Mycobacterium aurum.

Authors:  S Bosne-David; L Bricard; F Ramiandrasoa; A DeRoussent; G Kunesch; A Andremont
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

2.  Action of 1-isonicotinyl-2-palmitoyl hydrazine against the Mycobacterium avium complex and enhancement of its activity by m-fluorophenylalanine.

Authors:  N Rastogi; K S Goh
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

3.  The two-component regulatory system mtrAB is required for morphotypic multidrug resistance in Mycobacterium avium.

Authors:  Gerard A Cangelosi; Julie S Do; Robert Freeman; John G Bennett; Makeda Semret; Marcel A Behr
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

4.  Susceptibilities of transparent, opaque, and rough colonial variants of Mycobacterium avium complex to various fatty acids.

Authors:  H Saito; H Tomioka
Journal:  Antimicrob Agents Chemother       Date:  1988-03       Impact factor: 5.191

5.  PCR-restriction enzyme analysis of a bone marrow isolate from a human immunodeficiency virus-positive patient discloses polyclonal infection with two Mycobacterium avium strains.

Authors:  R S Oliveira; M P Sircili; S Y Ueki; M A Telles; B Schnabel; M R Briones; S C Leão
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

6.  A bone marrow-derived murine macrophage model for evaluating efficacy of antimycobacterial drugs under relevant physiological conditions.

Authors:  P S Skinner; S K Furney; M R Jacobs; G Klopman; J J Ellner; I M Orme
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

7.  Mycobacterium avium-intracellulare contamination of mammalian cell cultures.

Authors:  I H Lelong-Rebel; Y Piemont; M Fabre; G Rebel
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-10-15       Impact factor: 2.416

8.  Genes required for intrinsic multidrug resistance in Mycobacterium avium.

Authors:  Julie S Philalay; Christine O Palermo; Kirsten A Hauge; Tige R Rustad; Gerard A Cangelosi
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

9.  Enhancement of drug susceptibility of Mycobacterium avium by inhibitors of cell envelope synthesis.

Authors:  N Rastogi; K S Goh; H L David
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

Review 10.  The Mycobacterium avium complex.

Authors:  C B Inderlied; C A Kemper; L E Bermudez
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.